Certified by Founder Lodge
Engrail Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $157,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meani
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 20 ,2024 | Series B | $157,000,000 |
Eight Roads
F-Prime Capital
Red Tree Venture Capital
Forbion
RiverVest Venture Partners
Longwood Fund
Ysios Capital
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Sigma360 | $17,000,000 | (Mar 11, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
